Get the Stockscreener App
1.76
4.86%
-0.09
After Hours:
1.79
0.03
+1.70%
Tscan Therapeutics Inc stock is traded at $1.76, with a volume of 229.43K.
It is down -4.86% in the last 24 hours and up +5.39% over the past month.
TScan Therapeutics Inc is a biopharmaceutical company focused on the development of T-cell receptor (TCR) engineered T cell therapies (TCR-T) for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
See More
Previous Close:
$1.85
Open:
$1.85
24h Volume:
229.43K
Relative Volume:
0.63
Market Cap:
$92.35M
Revenue:
$21.05M
Net Income/Loss:
$-89.22M
P/E Ratio:
-0.9832
EPS:
-1.79
Net Cash Flow:
$-64.50M
1W Performance:
-7.85%
1M Performance:
+5.39%
6M Performance:
-2.22%
1Y Performance:
-68.23%
1-Day Range:
$1.72
$1.85
1-Week Range:
$1.72
$1.95
52-Week Range:
$1.02
$6.225
Tscan Therapeutics Inc Stock (TCRX) Company Profile
Name
Tscan Therapeutics Inc
Sector
Industry
Phone
857-399-9500
Address
830 WINTER STREET, WALTHAM
Compare TCRX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TCRX
Tscan Therapeutics Inc
|
1.76 | 104.42M | 21.05M | -89.22M | -64.50M | -1.79 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Tscan Therapeutics Inc Stock (TCRX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-16-24 | Initiated | BTIG Research | Buy |
| May-13-24 | Initiated | Needham | Buy |
| Jun-22-23 | Initiated | Wedbush | Outperform |
Tscan Therapeutics Inc Stock (TCRX) Latest News
Institutional scanner results for TScan Therapeutics Inc.CEO Change & Smart Swing Trading Alerts - Newser
Chart overlay techniques for tracking TScan Therapeutics Inc.July 2025 Momentum & AI Enhanced Execution Alerts - Newser
Is TScan Therapeutics Inc. stock poised for growthInsider Buying & Safe Capital Allocation Plans - Newser
Understanding TScan Therapeutics Inc.’s price movementJuly 2025 Update & Verified Momentum Stock Watchlist - Newser
Has TScan Therapeutics Inc. found a price floorProduct Launch & Low Risk Investment Opportunities - Newser
When is the best time to exit TScan Therapeutics Inc.Weekly Stock Summary & Safe Swing Trade Setup Alerts - Newser
Is TScan Therapeutics Inc. stock bottoming outJuly 2025 Trends & Weekly Return Optimization Alerts - Newser
How to use a screener to detect TScan Therapeutics Inc. breakoutsTrade Entry Report & Fast Moving Trade Plans - Newser
Using economic indicators to assess TScan Therapeutics Inc. potential2025 Price Action Summary & Free Real-Time Volume Trigger Notifications - Newser
Is TScan Therapeutics Inc. forming a bottoming base2025 Geopolitical Influence & Low Risk High Win Rate Picks - Newser
Pattern recognition hints at TScan Therapeutics Inc. upsideMarket Trend Summary & Smart Allocation Stock Tips - Newser
Visual analytics tools that track TScan Therapeutics Inc. performance2025 AllTime Highs & High Conviction Trade Alerts - Newser
Will a bounce in TScan Therapeutics Inc. offer an exitEarnings Recap Summary & Weekly High Return Stock Opportunities - Newser
Top chart patterns to watch in TScan Therapeutics Inc.Weekly Earnings Recap & Low Risk High Reward Ideas - Newser
Sector ETF performance correlation with TScan Therapeutics Inc.Earnings Performance Report & Accurate Buy Signal Notifications - Newser
Price momentum metrics for TScan Therapeutics Inc. explainedJuly 2025 PostEarnings & Real-Time Volume Analysis - Newser
What indicators show strength in TScan Therapeutics Inc.2025 Bull vs Bear & Verified Entry Point Detection - Newser
Is TScan Therapeutics Inc. showing signs of accumulation2025 Top Decliners & Daily Profit Focused Stock Screening - Newser
What institutional flow reveals about TScan Therapeutics Inc.Analyst Downgrade & Safe Capital Preservation Plans - Newser
How to monitor TScan Therapeutics Inc. with trend dashboardsWeekly Risk Summary & Smart Allocation Stock Reports - Newser
How to interpret RSI for TScan Therapeutics Inc. stock2025 Valuation Update & AI Powered Market Trend Analysis - Newser
Is TScan Therapeutics Inc. trending in predictive chart modelsEarnings Recap Report & Fast Entry Momentum Alerts - Newser
is tscan therapeutics inc. stock bottoming outJuly 2025 Price Swings & Capital Efficient Trade Techniques - Newser
TScan Therapeutics Inc. stock prediction for this weekJuly 2025 Reactions & High Accuracy Investment Signals - Newser
Can a trend reversal in TScan Therapeutics Inc. lead to recoveryIndex Update & AI Driven Stock Movement Reports - Newser
How to track smart money flows in TScan Therapeutics Inc.2025 Retail Activity & Verified Entry Point Signals - Newser
Checkpoint Capital L.P. Has $2.78 Million Stock Position in TScan Therapeutics, Inc. $TCRX - MarketBeat
Full technical analysis of TScan Therapeutics Inc. stockPortfolio Value Summary & Low Drawdown Investment Ideas - Newser
what makes tscan therapeutics inc. stock price move sharplyJuly 2025 Trade Ideas & Free Real-Time Market Sentiment Alerts - Newser
Volatility clustering patterns for TScan Therapeutics Inc.2025 Geopolitical Influence & Free Real-Time Volume Trigger Notifications - Newser
EcoR1 Capital LLC Decreases Holdings in TScan Therapeutics, Inc. $TCRX - MarketBeat
Tscan Therapeutics Inc Stock (TCRX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):